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Abstract 
Drug-like ligands obtained from protein–ligand complexes deposited in the Protein Databank were subjected to con-
formational searching using various force fields and solvation settings. For each ligand, the resulting conformer pool 
was examined for the presence of the bioactive (crystal pose-like) conformation. Similarity of conformers toward the 
crystal-pose was quantified as the best achievable root mean squared deviation (RMSD, heavy atoms only). Analyz-
ing the conformer pools generated by various force fields revealed only small differences in the likelihood of finding 
a crystal pose-like conformation. However, employing different solvents in the conformational search was found to 
be very important for achieving RMSDs below 1.0 Å. The best statistical values of likelihood were observed with a 
recently released force field covering a large portion of dihedral angles occurring in drug-like compounds in combi-
nation with the water as solvent. In order to enable computational chemists and modelers to efficiently use available 
software tools, we have additionally performed several focused analyses on ligands, grouped according to descriptors 
most relevant for the rational drug design.
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Background
In the last two decades, computational methods have 
found an established role in the rational drug design pro-
cess due to their invaluable help in interpreting experi-
mental results (e.g. NMR, X-ray), generating novel ideas 
based on theoretical models and navigating research 
steps with predictive tools. A large portion of the 
“rational” within computational methods stem from ana-
lyzing of structural information from X-ray crystal and 
NMR structures of ligand–protein complexes. To date, 
the most important repository of such structures—the 
Protein Data Bank (PDB) [1]—houses around 120,000 
biological macromolecular structures [2] (Accessed July, 
2016) and with each new entry improves our understand-
ing of the biologically and medicinally relevant phenom-
ena at the atomic level. As approximately one half of the 
entries have been deposited in the last 5  years, there is 
a need for periodic re-evaluation of our knowledge on 
both macromolecular targets as well as ligands interact-
ing with them.
In the rational drug design, computational chemists 
focus on ligand properties including conformational ones 
and fine tune ligand structure and pre-organization with 
the aim to minimize energetic penalties associated with 
undesired flexibility, sub-optimal arrangement of func-
tional groups interacting with the protein binding site or 
unwanted internal stabilization. When the 3D structure 
of the target protein is known (structure-based design), 
a modern lead optimization process often involves 
identifying reasonable binding poses and—most desir-
ably—also the bioactive one using molecular docking 
and scoring. As accounting for a full molecular flexibility 
of both ligand and protein simultaneously is extremely 
complex and currently far beyond our computational 
capacity, some docking approaches pre-generate reason-
able ligand conformers in a conformational search and 
then try inserting them into the (either rigid or flexible) 
binding site of the target protein looking for the best 
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possible complementarity of steric and electronic prop-
erties [3–8]. As an alternative to this approach, some 
protocols employ on-the-fly conformer generation in the 
receptor’s binding cavity [9, 10] or rely on the fragment 
based docking with a full rotational flexibility of dihedral 
angles [11, 12].
Favorable ligand conformations, resulting from a con-
formational search, are of key importance also in the 
ligand based design, when the structural information 
about the target is scarce or non-existent and therefore 
the binding hypothesis assuming the key-lock comple-
mentarity has to be derived from known ligands sharing 
a common 3D arrangement of functional groups (phar-
macophore) [13, 14].
The need for low-energy conformers, especially within 
the context of finding the bioactive conformation, has 
been long recognized. Therefore a number of differ-
ent search algorithms and sampling methods have been 
developed and implemented in protocols for generat-
ing conformers of small (drug-like) molecules [15–17]. 
Some tools rely on a systematic approach (i.e. CORINA 
[18, 19], ConfGen [3], OMEGA [20, 21])and some use a 
stochastic approach (i.e. BALLOON [22], RDKit [23]). 
Commonly used protocols such as Catalyst [24], MOE 
[25] and MacroModel [26] implement both approaches 
[15, 27]. Significance of the conformational sampling and 
challenges in finding the bioactive pose among an ensem-
ble of generated conformers were previously discussed in 
several studies [14, 28–32].
During a conformational search, the geometry optimi-
zation (energy minimization) of conformers is driven by a 
force field. A well-parameterized force field is thus a key 
prerequisite for ensuring that the resulting conformer 
pool includes the bioactive conformation (or one very 
similar to it). As the conformer energy is often the most 
important criterion for selecting, all force field terms for 
calculating energies (bonds, angles and dihedral angles, 
electrostatic and van der Waals (vdW), solvation con-
tributions) need to be accurate and mutually balanced. 
The performance of some force fields has already been 
assessed for specific sets of ligands or small peptides [33–
35]. In this study, we investigate several frequently used 
force fields (implemented in a popular commercial soft-
ware bundle [26]) for their ability to generate and rank 
bioactive conformations of a chemically very diverse set 
of drug-like ligands.
Methods
In order to perform focused analyses using in-house 
scripts and compiled software in a CPU-efficient man-
ner, a local mirror of the PDB was created (October 1, 
2014). Crystal structures of macromolecular targets, 
except of those containing nucleic acids, with at least 
one co-crystallized small ligand and the resolution bet-
ter than 1.6 Å (arbitrary threshold introduced to ensure 
solid quality of the structural data) were selected for fur-
ther analyses. As this study focuses on issues associated 
with the application of rational computer methods in 
drug design, drug-likeness of ligands found in such crys-
tal structures has been evaluated from several aspects.
Ligand selection
Our software analyzed composition of ligands including 
only those comprising of biogenic elements (C, H, N, O, 
S, P, F, Cl, Br, and I). Ligands covalently bonded to pro-
tein or those having unreasonably close contacts with 
water molecules were discarded (distance of the water 
oxygen atom toward any ligand heavy atom shorter than 
the sum of their vdW radii multiplied by a factor f; for 
carbon atoms f =  0.891, for all others f =  0.8). In case 
of alternate orientations for a single ligand, only the 
conformation with the highest occupancy was consid-
ered. If occupancy values for multiple orientations were 
equal, coordinates of the first encountered orientation (as 
appeared in the PDB file) were taken into account. Crys-
tal symmetry mates were generated (using a script from 
the Schrodinger library) for the asymmetric protein units 
and ligands in the vicinity of a neighboring crystal mate 
(within 5.0 Å from any ligand heavy atom), which might 
affect their pose and conformation by “artificial” packing 
effects, i.e. effects which would not occur in a free iso-
lated protein molecule, were discarded (1743 structures 
in total).
Ligand preparation
Hydrogen atoms were added to ligands based on the 
ligand templates from the curated library of ligands [36, 
37] (Accessed: November 28, 2015). The most probable 
protonation state for each ligand was predicted by Epik 
[38], at the pH used for crystallization (information on 
pH was read from the PDB file header), using water as 
solvent. Ligands containing multiple charged groups, 
with the total charge smaller than −3 or larger than +3 
were excluded from any further analyses.
Drug-likeness of ligands within this study was evalu-
ated based on descriptors proposed by Lipinski [39] and 
Veber [40], allowing for some tolerances for upper and 
lower limits. Ligand efficiency or potency descriptors 
could not be used for defining drug-likeness, as there 
are no standardized data available. All ligands stem from 
crystal structures so their sufficient water solubility is 
assumed. Number of rotatable bonds (#RotB), molecu-
lar weight (MW), and molecular surface areas (3D: MSA, 
PSA) were calculated by our program and crosschecked 
with the values provided by FaF-Drugs2 [41] (for #RotB) 
and QikProp [42]. Octanol–water partition coefficient 
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(LogP o/w) was estimated and the number of heavy 
atoms (#HA) was calculated by QikProp. Polar surface 
area (2D-PSA) was computed by OpenBabel [43, 44], 
where the total PSA equals to the sum of atomic contri-
butions. Descriptors, which were used for elimination 
and their threshold values, can be found in Additional 
file 1.
Further inclusion criteria
Several small molecules, such as crystallizing agents (e.g. 
citrate, PEGs, carboxylic acids) and prosthetic groups, i.e. 
vitamins, saccharides, or heme units, are present in the 
PDB with increased frequency. In a PDB file, these mol-
ecules are defined within the HETATM record along with 
small molecule ligands, but for the purpose of our study 
they were not classified as drug-like.
To avoid the bias caused by repeated occurrence of 
such structures in the data set, an occurrence analy-
sis (i.e. how many times a particular ligand is found in a 
protein–ligand complex) was performed for each ligand. 
Mean value and standard deviation of the ligand occur-
rence in the dataset were calculated (μ = 1.80, σ2 = 1.33). 
The threshold value was obtained by adding one standard 
deviation to the mean (3.13) and rounding it to the next 
higher integer value (4). Therefore, ligands that appeared 
more than four times in the raw data set were excluded 
to ensure diversity of data samples for unbiased statistical 
analyses. The PDB IDs of these excluded structures can 
be found in Additional file 1.
After the elimination due to molecular descriptors (510 
ligands) and frequency analyses (169 ligands; 14 unique 
structures), the final set of 809 ligands have maximum 15 
rotatable bonds, stay within the molecular weight range 
of 150–650 and consist of 10–150 heavy atoms. The PDB 
IDs of the 809 structures included in the final set can be 
found in Additional file  1 (the structures are also avail-
able in additional/supporting files).
Conformational search
A two-step conformational search was carried out for 
the final set of ligands by MacroModel [26]. The first 
step was incorporated into the search protocol with the 
aim to remove possible positive structural bias associ-
ated with the fact that the crystal conformation was used 
as input. In the first step, choosing OPLS_2005 [45] as 
the force field and GB/SA water model for the implicit 
solvation, a pool of conformers was generated for each 
ligand with mixed MCMM/Low-Mode conformational 
algorithm, by accepting all conformers with energies up 
to 50.0  kcal/mol from the global minimum. The maxi-
mum number of Monte Carlo steps was set to 5000. At 
maximum, 1000 conformers were saved for every indi-
vidual ligand.
Next, heavy-atom RMSDs were calculated between 
each conformer and the original crystal conforma-
tion (n.b. all RMSD calculations in this study are sym-
metry corrected, taking into account the structural 
automorphism; e.g. in case of a molecule containing a 
para-substituted benzene ring, the RMSD between two 
conformations is zero if these two conformations differ 
only by a 180° flip of the ring around the linker bond). 
The conformer with the highest RMSD from the crystal 
conformation, i.e. the most dissimilar one, was saved to a 
separate file and used as the input for the second step of 
conformational search.
The second—production—step of conformational 
search was performed using four different force fields—
OPLS3 [46], OPLS_2005 [45], MMFF94s [47] and 
AMBER* [48–50], with the same operating parameter 
settings as in the first step, except that the energy window 
was set to 5.0  kcal/mol, as in this step the low-energy 
conformers were of interest.
To evaluate the effect of different solvents, conforma-
tional searches were also done using octanol and chloro-
form. This solvent effect analysis follows the assumption 
that, e.g. a polar compound in a relatively hydropho-
bic protein binding site may adopt a collapsed bioac-
tive conformer (self-folded, stabilized by intramolecular 
interactions), which would be probably more similar to 
conformers optimized using the octanol or chloroform 
as solvent. If optimized in water, such a polar compound 
would benefit from favorable interactions with the sol-
vent environment and its conformers would extend to 
maximize the polar interactions, resulting in a conformer 
pool with members likely dissimilar from the bioactive 
conformer.
Using only heavy atoms, RMSD values were calculated 
between all conformers found in the production step and 
the original crystal conformation. The conformer with 
the lowest RMSD from the crystal conformation, i.e. the 
most similar one, was used in the following analyses and 
statistical comparisons.
Employing MD simulations with explicit solvent 
for conformer minimization
Random “raw” (not minimized) conformers generated 
by the MacroModel conformational search engine were 
used as input for a complex minimization protocol aim-
ing at mimicking “real world” conditions, i.e. those, 
which a free, unbound ligand experiences in an aqueous 
environment represented by explicit water molecules.
For all ligands, every single input conformer was 
placed in a TIP3P water-filled periodic boundary system 
(10.0 Angstrom cut-off in each Cartesian direction) and 
minimized (convergence criteria 0.5  kcal/mol). Next, a 
short 24 ps MD simulation using the NPT ensemble was 
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performed. In contrast with typical approaches where 
MD is employed to examine (sample) ligand’s dynamical 
freedom, our short MD run was included in the protocol 
only to allow for the conformer to adjust its shape and for 
water molecules to find their optimal position and orien-
tation with respect to the solute and neighboring waters.
After the MD simulation, the resulting periodic bound-
ary system was minimized again to eliminate small 
geometry distortions using the Desmond [51–53] mini-
mizer and finally also using the MacroModel minimizer 
(because of tighter convergence criteria). The resulting 
conformers were ranked based on their energies.
Due to explicit solvent conditions, the convergence of 
minimization was much worse than in case of implicit 
solvent, therefore a larger energy window was used (how-
ever, the final conformer counts were comparable with 
those obtained in conformational searches employing 
implicit solvent conditions).
Chemometric analysis
For all ligands included in this study, the most important 
physico-chemical descriptors related to rational drug 
design have been calculated using QikProp [42] com-
puter program and used for classification.
Results and discussion
This study aims at providing answers to several important 
questions relevant for the modern drug design: Is it pos-
sible to computationally generate crystal-pose-like (aka 
bioactive) conformations of drug-like molecules to be 
used for rational design purposes, e.g. for ligand docking 
or pharmacophore hypothesis based on ligands’ distance 
matrix? Are increased computational costs associated 
with “on the fly” ligand flexibility in docking justified or is 
it enough to prepare a pool of low energy conformers and 
reduce a rather complex docking procedure to “simple” 
accommodating of prepared conformers (without further 
modifying their geometry) into the protein binding site 
(with side-chains being either rigid or flexible)?
In the search for answers to these questions, statisti-
cal analyses were performed on conformer pools gener-
ated in conformational searches using various force fields 
(OPLS3, OPLS_2005, MMFF94s, AMBER*) and solvent 
conditions (implicit solvation models: water, octanol, 
and chloroform; explicit model: water; gas phase) for a 
set of drug-like ligands. In order to provide modelers and 
medicinal chemists with as much rational information 
as possible, detailed analyses were performed on ligands 
clustered according to various constitutional and phys-
ico-chemical descriptors.
The final dataset consisted of 809 drug-like mole-
cules. Averaged properties over the whole dataset were 
as follows: number of rotatable bonds #RotB was 5.4 
(min =  0, max =  15), molecular weight MW was 313.1 
(min  =  150, max  =  648), number of heavy atoms was 
21.6 (min  =  10, max  =  47), calculated LogP was 1.3 
(min = −5.0, max = 7.7), PSA was 103.0 Å2 (min = 0 Å2, 
max = 287 Å2).
Interpretation of conformational similarity based on key 
molecular descriptors
Number of rotatable bonds
The number of rotatable bonds (#RotB) was chosen as 
the main descriptor for the ligand classification, since 
variation of dihedral angles along rotatable bonds allows 
a compound to adopt distinct molecular shapes and spa-
tial distribution of its functional groups, which play the 
key role for molecular recognition (compound selectiv-
ity) and interaction pattern with macromolecular targets. 
#RotB is also the descriptor showing the highest correla-
tion to the RMSD of the most-crystal-like conformation 
(best RMSD OPLS 3.0: r2 = 0.546, n = 809).
Compounds having more than 15 rotatable bonds were 
excluded from further analyses, as with such an extreme 
conformational freedom (flexibility) the probability of 
finding the global minimum conformation and reason-
able low energy conformers decreases drastically even 
with the most advanced search algorithms. Moreover, too 
flexible compounds are not attractive from the point of 
rational drug design as they lose on their drug-likeness, 
due to a low expected biological availability after oral 
intake and large entropic penalties upon binding with the 
target macromolecule.
Based on #RotB, the data set was divided into four 
groups denoting their flexibility as: low (0 ≤ #RotB ≤ 3), 
fair (4 ≤ #RotB ≤ 6), high (7 ≤ #RotB ≤ 10) and extreme 
(11 ≤ #RotB ≤ 15). Table 1 and Fig. 1 contain results for 
each of the four force fields with implicit solvent (water) 
and energy window of 5.0 kcal/mol.  
For more than 90% of ligands in the cluster of rigid and 
low flexible compounds (#RotB ≤  3; n =  265), all force 
fields were able to generate a pool of conformers in which 
at least one conformer had a low RMSD (≤1.0 Å) from 
the reference crystal conformation (throughout the text, 
the term crystal conformation refers to the conforma-
tion of a particular ligand found in the protein binding 
site, not to be confused with a conformation of the ligand 
alone, e.g. in a small molecule crystal from the Cam-
bridge Structural Database [54]).
Regardless of the force field used, at least 78% of the 
ligands (n = 295) with 4 to 6 rotatable bonds had a con-
former within the RMSD range of 0–1.0 Å (in this #RotB 
cluster, the average score over all force fields is 87%). This 
is an encouraging observation, as most of the drug-like 
molecules are expected to fall into this range of rotatable 
bond counts, meaning that all force fields are well-suited 
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for modeling of leads or drug candidates, provided they 
meet also other drug-likeness criteria specified earlier.
Not surprisingly, finding a conformation with a 
low RMSD from the reference crystal conformation 
was less probable for highly flexible ligands (n  =  147; 
7 ≤  #RotB ≤  10). Still, with all force fields, at least one 
conformer with an RMSD lower than 1.0  Å within the 
5.0  kcal/mol energy window from the global minimum 
Table 1 Fraction (%) of ligands similar to the reference crystal pose based on RMSD
#RotB #Compounds 0–0.5 Å (%) 0–1 Å (%)
OPLS3 OPLS 2005 MMFFs AMBER* OPLS3 OPLS 2005 MMFFs AMBER*
0 34 100 97 100 100 100 100 100 100
1 77 92 86 88 91 100 99 100 100
2 59 81 68 76 73 98 93 97 97
3 95 69 60 58 77 99 94 92 99
4 131 68 47 53 56 95 86 90 94
5 87 53 38 36 34 97 86 90 84
6 77 30 27 22 26 84 83 79 78
7 47 13 11 13 4 77 66 64 59
8 52 6 6 6 4 62 62 63 54
9 30 0 7 0 0 48 47 43 45
10 18 6 0 6 6 56 44 50 44
11–15 102 0 1 1 0 32 30 28 31
Fig. 1 Comparison of results obtained for different force fields depending on ligand flexibility (#RotB)
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could be generated for about one half of the ligands (aver-
age score over all force fields is 55%) even with as much 
as 10 rotatable bonds. In the group of extremely flexible 
compounds (n = 102; RotB > 10), the probability of find-
ing a bioactive-like conformation in the conformer pool 
was only around 30%.
Overall, within ligands featuring up to 10 rotatable 
bonds, the conformers, which showed highest similarity 
to their crystal reference conformations (RMSD ≤ 1.0 Å), 
were generated most frequently by the OPLS3 force field.
Quite surprisingly, a rather narrow parameter set of the 
AMBER* force field focusing primarily on proteins and 
nucleic acids instead of on small molecules performed 
well on our PDB ligand selection (especially with less 
flexible ligands), closely followed by the MMFF94s and 
OPLS_2005 force fields (ranking by the total sum of the 
best RMSDs; Additional file 1: Table S6).
As can be seen, the number of ligands in each cluster 
according to rotatable bond counts was not equal. For 
example, while there were 131 ligands with four rotatable 
bonds in the data set, only 18 ligands had ten rotatable 
bonds. This fact has to be kept in mind when interpreting 
and implementing obtained statistical data for clusters 
with a relatively low number of ligands.
To have a better idea about the profile of the ligands 
which have a conformer with an RMSD smaller 
than 1.0  Å with respect to the crystal conformation 
(OPLS_2005, solvent: water), co-variation of some other 
descriptors were also assessed within different ranges of 
rotatable bond counts (Additional file 1: Table S1).
Rigid and the least flexible ligands (#RotB: 0–3) were 
likely to have a low molecular weight and less heavy 
atoms and quite as expected the opposite situation was 
likely for the most flexible ligands (#RotB: 10–15). Cal-
culated values showed that a high fraction (67%) of the 
ligands in the low-flexibility cluster had MW lower than 
250 Da and less than 15 heavy atoms (57%), whilst for the 
most flexible cluster, 20% of the ligands had MW lower 
than 250  Da and 11% had less than 20 heavy atoms. 
Effect of changes in MW and #HA was less pronounced 
for ligands which had a fair and a high flexibility (#RotB: 
4–10).
Molecular weight, number of heavy atoms and 
octanol–water partition coefficient were additional 
molecular properties associated with drug-likeness of 
molecules. Therefore, generated conformers (with best 
possible RMSD from the crystal reference) were classi-
fied also on these properties. These analyses offer a more 
comprehensive description of the chemical profile of the 
data set. Conformers obtained with the OPLS3 force field 
(solvent: water, energy window: 5.0 kcal/mol) were used 
for these analyses.
Molecular weight
Depending on the molecular weight (Additional file  1: 
Fig. S1) ligands were divided into four groups: the highest 
number of ligands (311 ligands) fell into the MW range of 
150–250 and the least populated was the range between 
450 and 650  Da (117 ligands). As much as 97% of the 
conformers from the lowest MW cluster could be gener-
ated with an RMSD below 1.0  Å. For the second (MW: 
250–350) and third (MW: 350–450) cluster, a smaller 
fraction of their ligands had at least one conformer below 
1.0 Å compared to the first cluster (87 and 72%, respec-
tively). This suggests that the probability of obtaining a 
low RMSD conformer (<1.0 Å) with respect to the crys-
tal conformation for ligands which stay within the broad 
MW range between 150 and 450 is expected to be higher 
than ~70%, whereas for the last cluster (MW: 450–650) 
this probability was significantly lower (46%).
It was previously reported that MW is also expected to 
increase as the #RotB increases [29]. To analyze this trend 
within our data set, the change of #RotB was tabulated 
for the MW ranges mentioned above (Additional file  1: 
Table S2). The gradual change with respect to rotatable 
bond counts was analogous for compounds in all MW 
clusters. Thus, the statistical data obtained for ligands in 
our data set also proves that the MW increases gradually 
as ligands become more flexible (#RotB increases).
Number of heavy atoms
The relationship between heavy atom counts and best 
achievable RMSDs was also examined on the very same 
conformer set as mentioned above (OPLS3, water, 5 kcal/
mol energy window). The ranges for clustering based on 
the number of heavy atoms were arbitrarily defined as: 
10–14, 15–20, 21–25, 26–30 and greater than 30 (Addi-
tional file 1: Fig. S2). At least 91% of the ligands with up to 
20 heavy atoms have at least one conformation with smaller 
RMSD than 1.0 Å in their low energy conformer pool. For 
the same RMSD range, a slight decrease was identified for 
the probability of finding a crystal-like conformer was iden-
tified for ligands with 21–30 heavy atoms (75%). However, 
a substantial increase of RMSD values was observed for 
ligands featuring more than 30 heavy atoms (47%).
Solvent effects based on octanol–water partition 
coefficient (implicit solvation model)
A special attention was paid to examining effects of vari-
ous solvents on the conformer generation. The data set 
was split into seven groups based on the octanol–water 
partition coefficient (LogP) (Additional file  1: Figs. S3–
S4) and conformers were generated using OPLS3 force 
field with varying solvents (water, octanol, or chloro-
form), but keeping all other settings unchanged.
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Theoretically, in a search for the bioactive conforma-
tion, ligands with a hydrophilic character (expressed as 
a low LogP value) and which—assuming the key-lock 
matching theory—likely bind to polar binding sites shall 
score better (in terms of a low RMSD to the reference), 
when the conformational search and especially minimi-
zation there within is performed using a polar solvent 
model (water) than when it is done in a low dielectric sol-
vent like octanol.
In analogy for lipophilic ligands (high LogP values) pre-
sumably binding to lipophilic binding sites, a higher simi-
larity of conformers and crystal poses would be expected, 
when searched using octanol as solvent. In such case, 
lipophilic groups preferring the interaction with the lipo-
philic solvent environment would drive the geometry 
optimization (minimization) toward extended conforma-
tions in order to maximize their contact (solvent-accessi-
ble) surface. On the other hand, using the water solvation 
model with a ligand having lipophilic groups might result 
in (hydrophobically) collapsed conformations due to 
their tendency to minimize their exposure to the polar 
solvent.
Finally, simulating a hydrophilic ligand, featuring mul-
tiple H-bond donors and acceptors in a lipophilic solvent, 
would promote increased formation of intramolecular 
hydrogen bonds, as no (or too little) competing H-bond-
ing counterparts are provided from the solvent. In any 
case, internally over-stabilized conformations generated 
in the conformational search would be less suitable as 
pose candidates, since their ability to form directional 
intermolecular H-bonding or hydrophobic interactions 
within the binding site would be compromised.
The analysis of results did not show any clear trend indi-
cating improved probabilities for a particular combination 
of ligand’s calculated LogP and used solvent. In most cases, 
conformers generated using octanol were less crystal-
pose like with the exception of one LogP group (4.0–4.99, 
RMSD range <1.0 Å). However, the plot of the best RMSDs 
for all ligands with the same force field but different sol-
vent (Additional file 1: Fig. S5) showed that solvent effects 
are mixed, i.e. conformers of some ligands benefit (points 
below the diagonal indicate ligands whose best RMSD 
toward reference is better in octanol than in water), but a 
slight majority actually worsen (points above the diagonal) 
their crystal-pose likeness. This observation suggests that 
each ligand has its own sensitivity towards varying sol-
vents, which cannot be reduced to a simple LogP param-
eter. Whether such mixed effects are related to the nature 
of the binding site will be the subject of our further studies.
Impact of explicit solvation model
To complement this type of ligand-solvent analysis, we 
generated conformers of each ligand (starting from same 
random conformations as in all other searches) also using 
explicit solvent conditions. Initial minimization, followed 
by an MD simulation and a final re-minimization should 
ensure that both ligand and water molecules surrounding 
it adopt the most favorable mutual orientation allowing 
for a more realistic treatment of particular solvent effects 
(e.g. bridging waters, hydrophobic effects). Despite large 
computational costs (~602 k MD simulations!), no signifi-
cant improvement of similarity to crystal pose conforma-
tions was observed in general. Just like with the implicit 
octanol solvation, conformations of some ligands became 
more crystal-like, but a slight majority of ligands suffered 
from an increase in the best achievable RMSD value.
General observations on solvent effects
Employing some kind of (either implicit or explicit) sol-
vation model in a conformational search seems to have 
a large beneficial impact on the ligand geometries, if 
similarity to co-crystalized conformations is the primary 
objective.
In our study, both conformational searches featur-
ing ligand minimization in the gas phase (once with 
the OPLS3 force field in MacroModel, once with the 
MMFF94s force field as implemented in OpenBabel) led 
to largely worsened results, i.e. the best RMSDs were 
much higher (i.e. conformers were not crystal pose-like) 
when compared to those obtained from “solvated” mini-
mizations (Additional file 1: Table S6).
Interestingly, the descriptor polar surface area (PSA) 
of a ligand related to solvation showed an apparent nega-
tive correlation with the crystal-pose likeness (Additional 
file 1: Fig. S6). While for as much as 64% of ligands with a 
low PSA (below 70 Å2) at least one very crystal-pose like 
conformer (RMSD < 0.5 Å) can be found in the conformer 
pool, this fraction drops to 10% with ligands featuring a 
large PSA above 210 Å2. However this observation is very 
likely biased by the fact that with an increasing PSA of 
ligands, their overall conformational complexity (more 
rotatable bonds, more heavy atoms) might rise as well.
But, if PSA is corrected in respect to the total SASA 
(Additional file 1: Figs. S7–S8), the trend gets weaker (if 
percentages cover RMSDs below 1.0 Å) or even reversed 
(if only those below 0.5 Å are counted), meaning that for 
compounds with a higher fraction of polar surface area 
(>0.4), crystal-like conformers are generated more easily 
(57% of ligands have a conformer with the best RMSD 
below 0.5 Å) than for those being less polar or completely 
apolar (41% with ligands having PSA/SASA below 0.1).
Effect of increased energy window on conformational 
search results
Statistically, enlarging the energy window (EW) for 
accepting conformers in a conformational search may be 
Page 8 of 13Gürsoy and Smieško  J Cheminform  (2017) 9:29 
directly associated with an increased probability of find-
ing a matching conformer in the resulting conformer 
pool.
If the crystal pose-like conformation, on the poten-
tial energy surface lies high above the global minimum 
energy conformer taken as a basis for positioning of the 
energy window, which if too small, would not include 
that particular conformer in the final pool. However at 
the same time, the number of conformers accepted for 
each molecule in the data set would increase requiring 
more computational time for their further processing 
(typically docking and scoring).
To examine these effects on our dataset of drug-like 
compounds, EW was lifted to 10.0  kcal/mol for con-
formational searches with OPLS3, OPLS_2005 and 
MMFF94s force fields. While with the 5.0 kcal/mol EW 
85% of molecules in the data set had conformations 
with RMSD smaller than 1.0 Å, with 10 kcal/mol EW an 
increase to 89.7% was observed. However the total num-
ber of all conformations was 3.4 times higher and the 
overall RMSD improvement was not significant (average 
RMSD improvement per compound: 0.05 Å).
Increased number of conformers was obviously most 
prominent for compounds having larger #RotB. There-
fore, we conclude that a relatively small increase in the 
success rate does not appropriately justify for a large 
increase of processing costs if EW of 10.0  kcal/mol is 
used (e.g. in high-throughput virtual screening), espe-
cially with very flexible compounds.
Still, if the maximum accuracy within a narrow set of 
ligands is desired (lead optimization), enlarging EW 
might help to increase likelihood of finding crystal-like 
conformers. In our dataset, 35.1% of ligands (OPLS3, sol-
vent: water) had the bioactive pose within 1.0 Å from the 
global minimum structure, which supports the idea of 
setting a reasonable energy cut-off for selecting conform-
ers to the final pool (For other force field-solvent combi-
nations: Additional file 1: Table S7).
Using NMR models as input for conformational analyses
Throughout this study, the RMSD on heavy atoms is used 
as a measure of similarity of a computationally gener-
ated conformer and the crystal pose of the corresponding 
ligand. Calculating the RMSD has been previously criti-
cized, however, it still remains the most frequently used 
parameter for describing similarity of conformers [16, 33, 
55–57].
In order to answer the question, how appropriate and 
sensitive such RMSD evaluation is in our study and 
how its magnitude compares with the experimentally 
observed conformational fluctuation, we analyzed also 
ligand models determined by the nuclear magnetic reso-
nance (NMR) deposited within the PDB.
Of identified 120 structures determined by the solution 
NMR, 75 had an ensemble of multiple models (5–60) 
and fulfilled the same criteria used for selecting ligands 
from crystal structures (150  <  MW  <  650, #RotB  <  15, 
10  <  #HA  <  150). For each ligand, inter-model RMSDs 
were calculated (each model vs. all other models), fol-
lowed by a determination of the arithmetic mean. Aver-
age inter-model RMSD values varied between 0.004 and 
1.265 Å and show how much natural fluctuation occurs 
within ligands bound to protein (Fig. 2).
This analysis seems to justify setting 1.0 Å as the upper 
limit for describing a good conformational similarity of 
conformers and crystal poses (acceptable for further pro-
cessing—scoring or MD simulation), as conformational 
fluctuation of this magnitude is indeed normal.
As expected, plotting the distribution of inter-model 
RMSD values against the #RotB descriptor (Additional 
file  1: Figs. S9–S10) confirms that with an increased 
conformational freedom of the ligand (higher #RotB) 
the chance of more pronounced geometry fluctua-
tions rises—a fact that should be reflected upon when 
evaluating RMSD values for larger and more flexible 
compounds.
This can be further supported by the statistical analysis 
of RMSD increase per rotatable-bond (crystal structures 
data set; conformer to crystal pose conformation com-
parison), showing that each rotatable bond causes “wors-
ening” of the best achievable RMSD by 0.13(±  0.02)  Å 
with only tiny differences among various force fields, if 
water is used as solvent (Additional file 1: Table S6).
It is also worth mentioning that no correlation could be 
detected between the number of models an NMR struc-
ture has and the average inter-model RMSD value (Addi-
tional file 1: Fig. S11), thus the results are not biased this 
way.
Fig. 2 Fifteen NMR models of the same ligand (extracted from the 
PDB entry 1LXF)
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Impact of charged groups
Presence of the charged groups in ligands (n.b. in our 
study the protonation state is assigned according to the 
pH of the crystallizing solution) and their effect on con-
formers were investigated, too. Most of the ligands (77%) 
in our data set had either none or one charged group in 
their structure. Only a few ligands (6 in total) had up to 5 
charged groups, which—besides being extremely polar—
were also considered less drug-like due to their high 
molecular weight or high flexibility.
As a general trend for all force field-solvent combi-
nations, as the number of charged groups on ligands 
increased, the similarity of their conformers to their 
crystal reference structures decreased (higher RMSD per 
compound, (Additional file  1: Table S3). This observa-
tion is related to the fact that charged groups can interact 
(attractively/repulsively) with each other over large dis-
tances (Coulomb’s law) and the associated electrostatic 
interaction energy is relatively high compared to other 
terms (e.g. torsional energy, hydrophobic interaction).
Comparison of per compound RMSDs between dif-
ferent solvents revealed that the best performance was 
achieved when water was the solvent, independent of the 
employed force field (Additional file  1: Table S3). Since 
the protonation states of ligands were assigned using 
water as solvent, this finding led us toward the idea of 
using the neutralized form of ligands for performing the 
conformational search with non-aqueous solvents. The 
results showed that per compound RMSD values were 
considerably better for all force field-solvent combina-
tions; more significantly when chloroform and octanol 
were used as solvent (Additional file 1: Table S4).
For molecules that are large and flexible, the presence 
of charged groups can result in distorted conformations, 
as usually there is no counter-balancing charge present 
in the environment during conformational searching. 
Therefore, when employing neutral species, the improve-
ment was bigger for the large and flexible molecules with 
several charged groups. Zwitterionic and flexible com-
pounds, in which the oppositely charged groups were 
located distally, showed dramatic changes in the similar-
ity of the output conformations (of the conformational 
search) to their crystal pose conformations.
A representative example is depicted in Fig.  3a (PDB 
ID: W2X), where the presence of a salt bridge between 
the amino group and the carboxyl group prevented a 
non-bridged extended conformation from being accepted 
during the conformational search (crystal conformation: 
green, most similarly generated conformation: orange, 
RMSD: 2.63 Å). Neutralization of ligand’s charged groups 
(to be used as input structure for the conformational 
search) rendered the electrostatic interaction between 
the oppositely charged groups less important, allowing 
the output conformers to adopt a more extended confor-
mation, similar to the crystal pose (Fig. 3b, RMSD: 0.85).
Another example can be seen in Fig.  3c (PDB ID: 
OCV), where the intramolecular interaction between 
the thiol group and carboxyl group hinders the mole-
cule from adopting an extended conformation and neu-
tralization of the molecule before conformational search 
allowed such an extension, which resulted in finding in a 
highly similar conformation to the crystal pose (Fig. 3d) 
in the final conformer pool.
A, B (PDB ID): W2X, lower pane; C, D (PDB ID): OCV. 
Green: crystal pose, orange: charged conformation, plum: 
neutralized conformation.
Taking a closer look on the ligands highlighted that the 
improvement was distributed over a large fraction of the 
ligands in the data set, and these ligands did not share 
any specific chemical characteristic apart from possess-
ing charged groups in their molecule. This led us to the 
idea of generating a pool of conformers for each ligand by 
combining the conformers resulting from both the con-
formational search with the charged input and the con-
formational search with the neutralized input. The most 
similar conformer to the crystal pose was then selected 
from a combined pool.
A striking improvement was achieved in the averaged 
best achievable RMSD (sum of minimum RMSDs of all 
ligands divided by total number of ligands; 809) for all 
force field-solvent pairs, if the lowest RMSD conformer 
was selected from the ligand’s combined conformer pool 
(Additional file  1: Table S5). RMSD values (per com-
pound) decreased 18.0–20.8% when the solvent used 
was octanol or chloroform. Although the initial objec-
tive of this analysis was to examine the outcome with two 
non-aqueous solvents, a substantial improvement was 
observed also within the results with water solvation. The 
fraction of the ligands, which have a conformer below 
RMSDs of 0.5 and 1.0  Å were determined (Table  2) for 
both the neutral and the combined dataset.
The combined pool of conformers showed an aver-
age improvement of 8.5% for the ligands that rank below 
1.0  Å (4.0% minimum for AMBER-water, 11.5% maxi-
mum for OPLS2005-chloroform). Figure 4 shows results 
for the four force fields with implicit solvent (water) and 
energy window of 5.0  kcal/mol, when the most similar 
conformer to the crystal pose was selected from the com-
bined pool of charged and neutralized conformers. It can 
clearly be seen that in all, from the most rigid to most 
flexible compounds, the fraction of ligands with best 
achieved RMSDs below 1.0 Å increased considerably.
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Fig. 3 Most similar charged and neutralized conformers superimposed onto the crystal conformation. a (PDB ID: W2X): superposition of the most 
similar charged conformer onto the crystal conformation, b (PDB ID: W2X): superposition of the most similar neutralized conformer onto the crystal 
conformation, c (PDB ID: OCV): superposition of the most similar charged conformer onto the crystal conformation, d (PDB ID: OCV): superposition 
of the most similar neutralized conformer onto the crystal conformation. Green crystal conformation, orange charged conformation, plum neutral-
ized conformation
Table 2 Fraction (%) of ligands similar to the reference crystal pose depending on charge and solvent
Conformer RMSDs were calculated taking crystal pose as reference for; (I) conformational search performed with charged input structures, (II) conformational search 
performed with neutralized input structures, (III) combined pool of (I) and (II)
Force field Charged (I) Neutralized (II) Combined (III)
<0.5 Å <1.0 Å <0.5 Å <1.0 Å <0.5 Å <1.0 Å
OPLS2005-chloroform 38.6 68.4 43.5 77.1 47.3 79.9
OPLS2005-octanol 40.8 71.1 45.0 77.5 48.9 80.1
OPLS2005-water 39.9 76.9 47.1 82.2 49.6 84.7
MMFFs-chloroform 35.8 67.6 43.4 74.4 46.1 77.9
MMFFs-octanol 40.4 71.1 45.1 79.1 48.2 82.3
MMFFs-water 40.9 77.4 47.3 81.7 50.2 84.3
AMBER-chloroform 36.7 67.5 43.0 75.0 46.2 77.8
AMBER-octanol 38.3 69.2 44.7 76.0 46.6 78.2
AMBER-water 43.1 77.4 45.5 79.0 48.6 81.3
OPLS3-chloroform 39.6 69.3 46.8 74.2 49.9 79.0
OPLS3-octanol 43.8 74.4 50.2 79.0 53.4 82.1
OPLS3-water 47.8 81.6 53.5 81.7 57.4 86.8
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Conclusion
Performing conformational searches (and geometry 
minimizations within) for drug-like ligands in order to 
prepare a pool of conformers with a high likelihood of 
containing the bioactive (crystal pose-like) conformation 
is most feasible using implicit water solvation. In some 
cases augmenting the final conformer pool with con-
formers obtained using other solvents or explicit water 
model can increase the probability of finding the crystal-
like conformation. For a vast majority of ligands with up 
to six rotatable bonds the crystal-like conformers can be 
accurately generated, however with larger rotatable bond 
counts the conformers gradually lose their accuracy even 
with the most advanced force field.
For more flexible compounds or in cases where there 
is some evidence of increased conformational strain 
required for binding, enlarging the energy window might 
be of help, of course at a price of increased computational 
cost.
The differences among various force fields in terms of 
the best achievable RMDS are small, nevertheless the 
most recently released OPLS3 parameter set covering 
a large variety of dihedral angles proves its expected 
superiority.
Focused analyses on ligands grouped according to the 
most relevant physico-chemical descriptors (Lipinski’s 
rule of 5 and Veber rules) did not show any significant 
inter-group differences or trends that could be prospec-
tively used when preparing conformer pools for further 
processing (docking and scoring, or pharmacophore 
concept).
A higher number of charged groups in the molecule 
(at pH of the crystallizing solution), capable of forming 
strong distorting (attractive of repulsive) interactions, 
is the best indicative of a poor RMSD from the refer-
ence crystal conformation. Neutralizing charged groups 
before conformational searching increases the likeli-
hood of finding extended crystal-like conformations. For 
achieving the best results, conformers generated based 
on the neutral species (after re-assigning the assumed 
protonation state) can be combined into one pool with 
the charged ones.
The analysis of ligands in NMR models helped to quan-
tify normal conformational fluctuations and showed a 
Fig. 4 Comparison of results obtained using combined pool of charged and neutralized conformers. For other force field-solvent combinations, the 
corresponding plots for neutralized conformers and combined pool of conformers (neutralized and charged) can be found in Additional file 1
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trend of increasing inter-model RMSDs with increasing 
conformation degrees of freedom. This observation is 
in analogy with the stepwise worsening (0.13  ±  0.02  Å 
per rotatable bond) of the best achievable RMSD upon 
increasing #RotB seen with conformers and their crystal 
pose conformation.
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